Estado
155%
financiada
Compartir
Datos de financiación (05/11/2020)
Contribuido
GBP
415.710,00
Objetivo máximo
GBP
267.000,00
Detalles
País
Reino Unido
Tipología
EquitySpain
Fecha final
05/11/2020
(1261 días)
contribuidores
650
Descripción
“Focusing on a $651m market, growing due to increased life expectancy and diseases related to ageing, REGEMAT 3D develops biofabrication devices to create tissues and organs, accelerating research in the laboratory. With 2019 sales of c. €682,9k, their devices are now being used in >25 countries.”